Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Omnicom Group Inc. (OMC) Price & Performance

BioNTech SE - ADRTrade
Omnicom Group Inc.Trade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Omnicom Group Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Omnicom Group Inc. trades at $85.82 (market cap $23.58B). The key difference: BioNTech SE - ADR and Omnicom Group Inc. are close in size by market cap, and Omnicom Group Inc. pays a 3.72% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXOMC
Market Cap
$23.31B$23.58B
Sector
HealthMedia
52-Week High
$119.34$86.22
52-Week Low
$83.89$67.27
Enterprise Value
$6.60B$31.66B
Dividend Yield
3.72%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNTech SE - ADR

No Aura AI signal available yet.

Omnicom Group Inc.

Omnicom Group (OMC) trades at $84.65, down 0.69% on the day, with a bullish technical outlook per moving averages but mixed oscillators. Recent Q2 2026 earnings beat expectations with $2.65 EPS, driven by 6.1% organic revenue growth and margin expansion post-Interpublic acquisition. The company maintains a 4% dividend yield and active buybacks, though high P/E of 232.3 reflects net income volatility.

Outlook is positive with analyst consensus target of $107.00 (27% upside), but risks include integration costs, debt increase, and competitive pressures. The stock offers value from synergy realization and AI-driven growth initiatives, yet investors must monitor execution on cost savings and organic growth sustainability amid economic uncertainties.

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Omnicom Group Inc.

Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.

Read more on OMC